Buspirone Hydrochloride Tablet
NDC Package 65841-784-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Buspirone Hydrochloride tablets is a human prescription drug administered via oral route. This formulation utilizes a tablet delivery system. Marketed by Zydus Lifesciences Limited, this product is identified by NDC 65841-784 and is authorized under FDA application ANDA078888.

Identification & Billing

NDC Package Code
65841-784-10
Package Description
1000 TABLET in 1 BOTTLE
Product Code
65841-784
11-Digit Billing Format
65841078410
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Buspirone Hydrochloride
Non-Proprietary Name
Buspirone Hydrochloride
Substance Name
Buspirone Hydrochloride
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
BUSPIRONE HYDROCHLORIDE 30 mg/1

Regulatory & Marketing

Labeler Name
Zydus Lifesciences Limited
Product Type
Human Prescription Drug
FDA Application #
ANDA078888
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-03-2014
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (65841-784). Click a package code to view its specific billing and regulatory data.

65841-784-05
500 TABLET in 1 BOTTLE
65841-784-14
60 TABLET in 1 BOTTLE
65841-784-77
100 BLISTER PACK in 1 CARTON / 1 TABLET in 1 BLISTER PACK (65841-784-30)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 65841-784-10 identifies a specific commercial package of 1000 tablet in 1 bottle of Buspirone Hydrochloride, a human prescription drug labeled by Zydus Lifesciences Limited. This tablet is formulated for oral use and contains buspirone hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zydus Lifesciences Limited on May 03, 2014. The current certification is valid through December 31, 2027.

How is this Zydus Lifesciences Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 65841078410. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
65841-784-10
11-Digit CMS (5-4-2)
65841-0784-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.